Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Olson

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Arthritis Care & Research|October 15, 2010
Defining quality of care in rheumatology: the American College of Rheumatology white paper on quality measurementKenneth G Saag, Jinoos Yazdany, Christopher Alexander, et al.
Survey of Ophthalmology|March 20, 2008
Re-engineering the resident applicant selection process in ophthalmology: a literature review and recommendations for improvementAndrew G Lee, Karl C Golnik, Thomas A Oetting, et al.
Plos One|December 21, 2017
Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learningMichael R Weed, Joseph Polino, Laura Signor, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2018
Discovery of morpholine-based aryl sulfonamides as Na<sub>v</sub>1.7 inhibitorsYong-Jin Wu, Jason Guernon, Andrea McClure, et al.
JACC. Cardiovascular Imaging|April 8, 2017
Systematic CT Methodology for the Evaluation of Subclinical Leaflet ThrombosisHasan Jilaihawi, Federico M Asch, Eric Manasse, et al.
Arthritis Care & Research|July 9, 2016
Methods for Developing the American College of Rheumatology's Electronic Clinical Quality MeasuresJinoos Yazdany, Rachel Myslinski, Amy Miller, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor AgonistsMatthew D Hill, Haiquan Fang, H Dalton King, et al.
Plos One|July 29, 2016
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of SchizophreniaLinda J Bristow, Amy E Easton, Yu-Wen Li, et al.
Journal of Medicinal Chemistry|February 25, 2017
Development of New Benzenesulfonamides As Potent and Selective Na<sub>v</sub>1.7 Inhibitors for the Treatment of PainYong-Jin Wu, Jason Guernon, Jianliang Shi, et al.
Bioorganic & Medicinal Chemistry|August 19, 2017
Discovery of non-zwitterionic aryl sulfonamides as Na<sub>v</sub>1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activationYong-Jin Wu, Jason Guernon, Andrea McClure, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Arthritis Care & Research|October 15, 2010
Defining quality of care in rheumatology: the American College of Rheumatology white paper on quality measurementKenneth G Saag, Jinoos Yazdany, Christopher Alexander, et al.
Survey of Ophthalmology|March 20, 2008
Re-engineering the resident applicant selection process in ophthalmology: a literature review and recommendations for improvementAndrew G Lee, Karl C Golnik, Thomas A Oetting, et al.
Plos One|December 21, 2017
Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learningMichael R Weed, Joseph Polino, Laura Signor, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2018
Discovery of morpholine-based aryl sulfonamides as Na<sub>v</sub>1.7 inhibitorsYong-Jin Wu, Jason Guernon, Andrea McClure, et al.
JACC. Cardiovascular Imaging|April 8, 2017
Systematic CT Methodology for the Evaluation of Subclinical Leaflet ThrombosisHasan Jilaihawi, Federico M Asch, Eric Manasse, et al.
Arthritis Care & Research|July 9, 2016
Methods for Developing the American College of Rheumatology's Electronic Clinical Quality MeasuresJinoos Yazdany, Rachel Myslinski, Amy Miller, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor AgonistsMatthew D Hill, Haiquan Fang, H Dalton King, et al.
Plos One|July 29, 2016
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of SchizophreniaLinda J Bristow, Amy E Easton, Yu-Wen Li, et al.
Journal of Medicinal Chemistry|February 25, 2017
Development of New Benzenesulfonamides As Potent and Selective Na<sub>v</sub>1.7 Inhibitors for the Treatment of PainYong-Jin Wu, Jason Guernon, Jianliang Shi, et al.
Bioorganic & Medicinal Chemistry|August 19, 2017
Discovery of non-zwitterionic aryl sulfonamides as Na<sub>v</sub>1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activationYong-Jin Wu, Jason Guernon, Andrea McClure, et al.
Pageof 4